Lilly’s legal offensive against compounders of its popular weight loss drugs hits another snag in court.

As researchers scramble to develop compounds that will be even safer and more effective for weight loss than currently ...

Eli Lilly's experimental weight-loss pill showed superior blood sugar control in diabetic patients across two late-stage ...

Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Eli Lilly and Company recently completed ...

Eli Lilly said on Wednesday its experimental pill, orforglipron, helped reduce blood sugar levels in two late-stage trials. The oral drug is designed to mimic the appetite-suppressing GLP-1 hormone ...

Eli Lilly and Company's strong Phase 3 diabetes drug results boost its GLP-1 franchise. Click for my updated look at LLY ...

Lilly’s weight loss pill succeeds in late stage trial; Novo acquires a new drug; Pfizer on U.S.-China partnerships.

Eli Lilly (NYSE: LLY) is now known for its weight loss drugs. Its stock has risen 150% since mid-2022 because of high demand ...

Although it is a major AI infrastructure operator, Oracle's excessive reliance on a few mega-deals and its high capital ...